Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography

Auris Nasus Larynx

Volumn 35, Issue 1, 2008, Pages 103-108

  Horiuchi, Choichi ^a   Taguchi, Takahide ^a   Yoshida, Takafumi ^a   Nishimura, Goshi ^a   Kawakami, Mariko ^a   Tanigaki, Yuji ^a   Matsuda, Hideki ^a   Mikami, Yasukazu ^a   Oka, Takashi ^a   Inoue, Tomio ^a   Tsukuda, Mamoru ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Assessment; Concurrent chemoradiotherapy; FDG PET; HNSCC

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE; UFT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BLOOD GLUCOSE; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OTORHINOLARYNGOLOGIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY DOSAGE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 37749052514     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2007.05.003     Document Type: Article

References (26)

1. Di Martino E., Nowak B., Hassan H.A., Hausmann R., Adam G., Buell U., et al. Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg. 126 (2000) 1457-1461
2. Paulus P., Sambon A., Vivegnis D., Hustinx R., Moreau P., Collignon J., et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 108 (1998) 1578-1583
3. Stokkel M.P., Moons K.G., ten Broek F.W., van Rijk P.P., and Hordijk G.J. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86 (1999) 2370-2377
4. McGuirt W.F., Greven K., Williams III D., Keyes Jr. J.W., Watson N., Cappellari J.O., et al. PET scanning in head and neck oncology: a review. Head Neck 20 (1998) 208-215 [review]
5. Rege S., Maass A., Chaiken L., Hoh C.K., Choi Y., Lufkin R., et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 73 (1994) 3047-3058
6. Stokkel M.P., Terhaard C.H., Hordijk G.J., and van Rijk P.P. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography. Oral Oncol 35 (1999) 390-394
7. Schechter N.R., Gillenwater A.M., Byers R.M., Garden A.S., Morrison W.H., Nguyen L.N., et al. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?. Int J Radiat Oncol Biol Phys 51 (2001) 4-9 [review]
8. Lowe V.J., Boyd J.H., Dunphy F.R., Kim H., Dunleavy T., Collins B.T., et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 18 (2000) 651-658
9. Goerres G.W., Schmid D.T., Bandhauer F., Huguenin P.U., von Schulthess G.K., Schmid S., et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 130 (2004) 105-109 [discussion 120-1]
10. Greven K.M., Williams III D.W., Keyes Jr. J.W., McGuirt W.F., Watson Jr. N.E., Randall M.E., et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74 (1994) 1355-1359
11. Terhaard C.H., Bongers V., van Rijk P.P., and Hordijk G.J. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 23 (2001) 933-941
12. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics 2005. CA Cancer J Clin 55 (2005) 10-30
13. Taguchi T., Ikeda Y., Mikami Y., Kawai S., Arai Y., Mochimatsu I., et al. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. Anticancer Res 23 (2003) 713-717
14. Katori H., Tsukuda M., Mochimatu I., Ishitoya J., Kawai S., Mikami Y., et al. Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 90 (2004) 348-352
15. Kostakoglu L., and Goldsmith S.J. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 45 (2004) 56-68 [review]
16. Rogers J.W., Greven K.M., McGuirt W.F., Keyes Jr. J.W., Williams III D.W., Watson N.E., et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?. Int J Radiat Oncol Biol Phys 58 (2004) 694-697
17. Higashi K., Clavo A.C., and Wahl R.L. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 34 (1993) 414-419
18. Nam S.Y., Lee S.W., Im K.C., Kim J.S., Kim S.Y., Choi S.H., et al. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. Oral Oncol 41 4 (2005) 390-395
19. Rege S., Safa A.A., Chaiken L., Hoh C., Juillard G., and Withers H.R. Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 23 (2000) 164-169
20. Kresnik E., Mikosch P., Gallowitsch H.J., Kogler D., Wiesser S., Heinisch M., et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 28 (2001) 816-821
21. Sakamoto H., Nakai Y., Ohashi Y., Matsuda M., Sakashita T., Nasako Y., et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol Suppl 538 (1998) 254-260
22. Lowe V.J., Dunphy F.R., Varvares M., Kim H., Wittry M., Dunphy C.H., et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18] fluorodeoxyglucose positron emission tomography. Head Neck 19 (1997) 666-674
23. Greven K.M., Williams III D.W., McGuirt Sr. W.F., Harkness B.A., D'Agostino Jr. R.B., Keyes Jr. J.W., et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 23 (2001) 942-946
24. Koike I., Ohmura M., Hata M., Takahashi N., Oka T., Ogino I., et al. FDG-PET scanning after radiation can predict tumor regrowth three months later. Int J Radiat Oncol Biol Phys 57 (2003) 1231-1238
25. Andrade R.S., Heron D.E., Degirmenci B., Filho P.A., Branstetter B.F., Seethala R.R., et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65 5 (2006) 1315-1322 [Epub 2006 Jun 5]
26. Fu K.K., Woodhouse R.J., Quivey J.M., Phillips T.L., and Dedo H.H. The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord. Cancer 49 (1982) 655-658